BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Reviva Pharmaceuticals
RVPH
$30.4M
| $0.4470 | $3 |
571%
upside
| Buy |
18 Aug ‘25
21 days ago |
|
|
LGVN
2
Longeveron
LGVN
$17.6M
| $0.8487 | $3 |
253%
upside
| Buy |
15 Aug ‘25
24 days ago |
|
3
Gain Therapeutics
GANX
$62.9M
| $1.75 | $6 |
243%
upside
| Buy |
13 Aug ‘25
26 days ago |
|
4
CervoMed
CRVO
$86.9M
| $9.99 | $16 |
60%
upside
| Buy |
12 Aug ‘25
27 days ago |
|
5
Capricor Therapeutics
CAPR
$290M
| $6.35 | $12 |
89%
upside
| Buy |
14 Jul ‘25
1 month ago |
|
|
VRNA
6
Verona Pharma
VRNA
$9.19B
| $106.30 | $116 |
9%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
7
PolyPid
PYPD
$55M
| $3.46 | $9 |
160%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
8
Cingulate
CING
$20.3M
| $3.75 | $11 |
193%
upside
| Buy |
19 May ‘25
3 months ago |
|
|
9
CervoMed
CRVO
$86.9M
| $9.99 | $20 |
100%
upside
| Buy |
18 Mar ‘25
5 months ago |
|
|
VRNA
10
Verona Pharma
VRNA
$9.19B
| $106.30 | $68 |
36%
downside
| Buy |
10 Jan ‘25
8 months ago |
|
|
11
Cingulate
CING
$20.3M
| $3.75 | $12 |
220%
upside
| Buy |
10 Jan ‘25
8 months ago |
|
|
12
Reviva Pharmaceuticals
RVPH
$30.4M
| $0.4470 | $7 |
1,466%
upside
| Buy |
10 Jan ‘25
8 months ago |
|
|
13
Gain Therapeutics
GANX
$62.9M
| $1.75 | $7 |
300%
upside
| Buy |
24 Dec ‘24
8 months ago |
|
14
Entrada Therapeutics
TRDA
$201M
| $5.28 | $29 |
449%
upside
| Buy |
5 Dec ‘24
9 months ago |
|
|
LGVN
15
Longeveron
LGVN
$17.6M
| $0.8487 | $10 |
1,078%
upside
| Buy |
5 Dec ‘24
9 months ago |
|